Pharmacotherapy for Pediatric Obesity: A Phentermine Clinical Trial
Status:
Withdrawn
Trial end date:
2028-06-01
Target enrollment:
Participant gender:
Summary
This is a multi-site, randomized, placebo-controlled clinical trial to examine the weight
loss efficacy and cardiovascular safety of phentermine 15 mg daily plus lifestyle therapy
versus placebo plus lifestyle therapy among 200 adolescents ages ≥10 to <18 years with
obesity.